EBITDA Margin ratio Analysis of Onconova Therapeutics Inc - Deep Dive
Latest FY EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-8923.89
Period Ending - Dec-22
Very Poor EBITDA Margin
-8684.51
Growth
-2.76 %
Trailing Twelve Months EBITDA Margin
Period Ending - Dec-23
Very Poor EBITDA Margin
-7956.64
Most recent Quarter EBITDA Margin
Period Ending - Mar-24
Very Poor EBITDA Margin
-7960.71
EBITDA Margin Analysis of Onconova Therapeutics Inc
Ebitda Margin Ratio of Onconova Therapeutics Inc with value of -7956.64 means that its operating expenses are Higher in relation to total revenue in trailing twelve months. |
Ebitda Margin Ratio of Onconova Therapeutics Inc with value of -7960.71 means that its operating expenses are Higher in relation to total revenue in latest Quarter ending on Mar-24. |
EBITDA Margin Ratio of ONTX has fallen by -2.76 % Compared to previous Financial Year. |
EBITDA Margin Ratio with value of -983.92 was highest in Year Dec-19 in last Five Years. |
EBITDA Margin Ratio with value of -10883.12 was lowest in Year Dec-20 in last Five Years. |
Latest EBITDA Margin Ratio with value of -8923.89 is lower than Average EBITDA Margin of -7324.20 in last five years. |
Ebitda Margin of Onconova Therapeutics Inc is negative because of negative EBITDA in last Financial Year , last Quarter and also in last twelve Months |
Other EBITDA Margin Related Info of ONTX that may interest you.
Onconova Therapeutics Inc Overview
Code | Price | Previous Price | Price Change | Sector |
---|---|---|---|---|
ONTX | 0.9953 | 1.0 | 0.470 % | Biotechnology |
Defination of EBITDA Margin
EBITDA Margin is the profitability ratio that measures a company's earnings before interest, taxes, depreciation, and amortization as a percentage of revenue. EBITDA is the abbreviation for Earnings before Interest, Taxes, Depreciation, and Amortization. more ..EBITDA Margin Related Ratios
NetProfitMargin | ReturnOnEquity |
Tsr Profitability Index
Poor Profitability Stock |
FY - Historical EBITDA Margin of Onconova Therapeutics Inc
Period | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | Dec-18 | Dec-17 |
---|---|---|---|---|---|---|---|
EBITDA Margin | -8923.89 | -8684.51 | -7145.58 | -10883.12 | -983.92 | -1680.94 | -3048.41 |
Change | -2.76 % | -21.54 % | 34.34 % | -1006.10 % | 41.47 % | 44.86 % | -764.47 % |
FY Chart of EBITDA Margin of Onconova Therapeutics Inc
Note : All Data Generated at the End of Trading Hours (EOD Data)